Dr David Munn reviews the basics of the immune system, including which parts are promising targets for cancer therapy.
This activity is intended for oncologists, pathologists, and other healthcare professionals who treat patients with cancer.
The goal of this activity is to review the workings of the immune system, including emerging approaches to harness it to develop cancer therapies.
Approximate Time to Complete: 1 hour
Course Available Beginning: Aug. 17, 2017
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the role of innate and adaptive immune cells in cancer prevention
- Have increased knowledge regarding the of the variety of methods tumors can use to avoid detection and/or elimination by the immune system
- Have increased knowledge regarding the of the means by which pathways within the immune system such as immune checkpoints and costimulatory molecules could be harnessed to induce tumor cell death